Search Results
- < Prev
1 of 1
- Next >
News Releases
-
Jun 17, 2013, 08:00 ET
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
Johnson & Johnson (NYSE: JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on drugs to treat hormonally-driven cancers. The acquisition includes Aragon's androgen receptor antagonist...
More news about: Johnson & Johnson , Aragon Pharmaceuticals, Inc. , Janssen Research & Development, LLC
- < Prev
1 of 1
- Next >
Modify your Search
 |
Quickly search for PR Newswire releases by adding our plugin to your browser search |